Recent advances of imidazole-containing derivatives as anti-tubercular agents

YL Fan, XH Jin, ZP Huang, HF Yu, ZG Zeng… - European journal of …, 2018 - Elsevier
Tuberculosis still remains one of the most common, communicable, and leading deadliest
diseases known to mankind throughout the world. Drug-resistance in Mycobacterium …

An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review

PS Girase, S Dhawan, V Kumar, SR Shinde… - European Journal of …, 2021 - Elsevier
Piperazine, is privileged six membered nitrogen containing heterocyclic ring also known as
1, 4-Diazacyclohexane. Consequently, piperazine is a versatile medicinally important …

An insight into the medicinal perspective of synthetic analogs of imidazole

S Rulhania, S Kumar, B Nehra, GD Gupta… - Journal of molecular …, 2021 - Elsevier
Imidazole remains a privileged heterocycle in drug discovery. Imidazole scaffold is a
ubiquitous motif that is present in several pharmacologically important drug molecules such …

The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax

CH Munkboel, TB Rasmussen, C Elgaard, MLK Olesen… - Toxicology, 2019 - Elsevier
Azole antifungal drugs are used worldwide to treat a variety of fungal infections such as
vulvovaginal candidiasis, particularly in pregnant women who are at increased risk. The aim …

Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies

AM Soliman, HAA Abd El-wahab, H Akincioglu… - Bioorganic …, 2024 - Elsevier
Abstract Development of Multitarget-Directed Ligands (MTDLs) is a promising approach to
combat the complex etiologies of Alzheimer's disease (AD). Herein we report the design …

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors

SM Kishk, KJ McLean, S Sood, D Smith… - …, 2019 - Wiley Online Library
The emergence of untreatable drug‐resistant strains of Mycobacterium tuberculosis is a
major public health problem worldwide, and the identification of new efficient treatments is …

Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors

LA Alshabani, A Kumar, SJ Willcocks… - RSC Medicinal …, 2022 - pubs.rsc.org
A series of imidazole and triazole diarylpyrazole derivatives were prepared using an efficient
5-step synthetic scheme and evaluated for binding affinity with Mycobacterium tuberculosis …

Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole–1, 2, 4‐Triazole Conjugates

KA Ajin, S Arun Kumar, M Singh… - Chemistry & …, 2023 - Wiley Online Library
Mycobacterium tuberculosis (Mtb) has numerous cell wall and non‐cell wall mediated
receptors for drug action, of which cell wall mediated targets were found to be more …

[HTML][HTML] Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1

SM Kishk, KJ McLean, S Sood, MA Helal… - Bioorganic & Medicinal …, 2019 - Elsevier
The rise in multidrug resistant (MDR) cases of tuberculosis (TB) has led to the need for the
development of TB drugs with different mechanisms of action. The genome sequence of …

Lipophilic quinolone derivatives: Synthesis and in vitro antibacterial evaluation

E Sadowski, B Bercot, A Chauffour, C Gomez… - Bioorganic & Medicinal …, 2022 - Elsevier
This paper reports on the design of a series of 10 novel lipophilic piperazinyl derivatives of
the 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid, their …